Compare Heron Therapeutics Inc (HRTX) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Unity Software Inc — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Unity Software Inc trades at $46.88 (market cap $20.20B). The key difference: Unity Software Inc is far larger — about 297× Heron Therapeutics Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Unity Software Inc for 50 Days on average.
| HRTX | U | |
|---|---|---|
Market Cap | $68.01M | $20.20B |
Volume | 1,891,941 | 15,432,191 |
Sector | Health | Technology |
52-Week High | $1.49 | $49.47 |
52-Week Low | $0.27 | $17.13 |
Typical Hold Time | 35 Days | 50 Days |
Enterprise Value | $174.75M | $20.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.4061, up 4.13% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics (-22.52% net margin), analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings call discussions.
HRTX faces significant fundamental challenges with consistent losses and negative ROE, though revenue stability provides some foundation. The strong analyst support suggests potential upside if operational improvements materialize, but high execution risk and cash flow concerns warrant caution for investors seeking near-term profitability.
Unity Software (U) trades at $45.89, up 0.99% today, with strong analyst support (83% buy ratings) and a $46.54 consensus price target. Recent momentum is fueled by Meta VR partnership news and positive technical signals, though the stock faces fundamental challenges with negative profitability metrics and consecutive earnings misses. Cash flow trends show improvement with 2025 operating cash flow reaching $423 million.
The stock presents a growth opportunity with accelerating strategic revenue and AI platform transformation, but carries significant risk from persistent losses and high valuation multiples. Investors must weigh strong institutional support against ongoing profitability challenges and competitive pressures in the gaming engine market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
